[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609737":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":18,"centralContacts":24,"locations":34,"responsibleParty":54,"collaborators":57,"id":63,"slug":7,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":7,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":7,"enrollmentInfo":71,"targetDuration":7,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":7,"overallStatus":36,"whyStopped":7,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Medical University of South Carolina","OTHER",null,[9,13,15],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"BEHAVIORAL","CBT4CBT (Computerized Cognitive Behavioral Therapy)","Participants will receive one therapist-led motivational interviewing\u002Fgoal setting session followed by 7 sessions of computerized CBT4CBT.",{"type":10,"name":14,"description":12,"armGroupLabels":7,"otherNames":7},"Motivational Interviewing",{"type":10,"name":16,"description":17,"armGroupLabels":7,"otherNames":7},"Contingency Management","Patients will receive contingent reinforcers (financial incentives for reduction in urinary cannabinoids).",[19,22],{"name":20,"affiliation":5,"role":21},"Rachel Tomko, PhD.","PRINCIPAL_INVESTIGATOR",{"name":23,"affiliation":5,"role":21},"Erin McClure, PhD.",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":7,"email":29},"Rachel Tomko, PhD","CONTACT","(843) 792-5447","tomko@musc.edu",{"name":31,"role":27,"phone":32,"phoneExt":7,"email":33},"Erin McClure, PhD","(843) 792-7192","mccluree@musc.edu",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Charleston","South Carolina","29425","United States",{"type":42,"coordinates":43},"Point",[44,45],-79.93275,32.77632,{"lat":45,"lon":44},[48,52],{"name":49,"role":27,"phone":50,"phoneExt":7,"email":51},"Kevin Branson, MA, ADC, MAC","843-792-0493","bransonk@musc.edu",{"name":26,"role":27,"phone":53,"phoneExt":7,"email":29},"843-792-5447",{"type":21,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Rachel Tomko","Associate Professor-Faculty",[58,61],{"name":59,"class":60},"National Institutes of Health (NIH)","NIH",{"name":62,"class":60},"National Institute on Drug Abuse (NIDA)","100609737",false,"NCT07218471","Cannabis Reduction and Functional Outcomes","Prospective Changes in Patient-reported and Objective Functioning Following Reduction of Cannabis Use","Inclusion Criteria:\n\n* Age 18+\n* Urinary cannabinoid level ≥ 50 ng\u002FmL\n* DSM-5 diagnosis of CUD (mild, moderate, or severe)\n* Willingness to attempt cannabis reduction\n* Completion of Intake Visit\n\nExclusion Criteria:\n\n* Serious medical\u002Fpsychiatric conditions\n* Pregnancy or breastfeeding\n* Use of cannabis in past 30 days was for medical purposes only\n* Discontinuation or reduction of cannabis use may exacerbate a pre-existing condition\n* Cognitive or understanding difficulties, as evidenced by inability to pass informed consent quiz","ALL","18 Years",{"count":72,"type":73},176,"ESTIMATED","INTERVENTIONAL",[76],"NA","This study evaluates the effects of cannabis use reduction among adults diagnosed with cannabis use disorder (CUD). Participants will undergo an 8-week intervention combining motivational interviewing, computerized cognitive behavioral therapy (CBT4CBT), and financial incentives for reduction in urinary cannabinoids. The study aims to assess improvements in cannabis-related problems, sleep, cognitive performance, CUD severity, and quality of life.",[79],"Cannabis Use Disorder","2026-03-16",{"date":82,"type":83},"2026-03-19","ACTUAL",{"date":85,"type":83},"2026-03-13",{"date":87,"type":73},"2030-01-30",{"name":5,"class":6},1]